七彩化學(300758.SZ):匹克投資累計減持246.3萬股 減持數量過半
格隆匯5月13日丨七彩化學(300758.SZ)公佈,2020年5月12日公司收到匹克投資出具的《關於減持鞍山七彩化學股份有限公司股份超過2%暨減持過半告知函》,匹克投資在2020年5月6日至2020年5月12日期間通過大宗交易方式減持103.00萬股,減持股份數量佔公司股份總數0.97%。
截止公告披露日(2020年5月13日)匹克投資通過集中競價交易方式減持33.30萬股,通過大宗交易方式減持213.00萬股,合計減持246.3萬股,佔公司股份總數2.31%,且較其預先披露減持計劃數量過半和累計減持超過公司股份總數2%。
此次減持後,匹克投資持有股份628.7萬股,佔總股份比例5.89%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.